01541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.95
+1.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.65x
- Price / sales
- 6.81x
- Price / cash flow
- -4.44x
Enterprise value
- Enterprise value
- HKD 525.6M
- EV / sales
- 2.95x
- EV / EBITDA
- -2.20x
- EV / EBIT
- -2.19x
- Market cap
- HKD 1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026